Avioq, Inc. is a medical device company established to develop and market high-quality immunodiagnostic products. On September 21, 2009, Avioq’s first product, the Avioq HIV-1 Microelisa System, received FDA approval for its use as an aid in diagnosis of HIV infection. In March of 2012 our RTP manufacturing facility was licensed by FDA for manufacture of the Avioq HTLV-I/II Microelisa System for blood donor screening. Please visit our web site at www.avioq.com to see our latest Labware offerings, featuring a variety of 96-well microplates and HDPE bottles.